March 14, 2018
This webinar will outline Biomodels’ experience and capabilities in conducting highly informative customized preclinical studies in translational oncology. We will discuss how preclinical models and strategies can be tailored to assess specific readouts in more biologically accurate and clinically recapitulative settings than ever before. Key topics will include model selection, combinations and adjuncts to current therapies, considerations in immunoncology, modeling relapse or resistance, models of metastasis, targeting tumor microenvironment, imaging modalities, biomarkers, next-generation humanized models, gnotobiotics and microbiome models, and more.
Event details available here.